6L9.F ViewRay, Inc. XETRA 21 Jan 2026: Intraday to €0.025 on heavy volume, watch levels
The 6L9.F stock jumped 2400.00% intraday to €0.025 on XETRA on 21 Jan 2026, driven by a short-lived volume spike of 3,500.00 shares. Traders flagged the move after the stock opened at €0.001 and printed a day high of €0.025. The sudden activity pushed the relative volume to 12.54 versus an average of 279.00 shares. We examine why ViewRay, Inc. (6L9.F) moved, how fundamentals and technicals line up on XETRA in Germany, and what traders should watch next.
Intraday price action for 6L9.F stock
One clear fact: 6L9.F stock traded a one-day range from €0.001 to €0.025 on XETRA with 3,500.00 shares changing hands. The change printed as +2400.00% versus the previous close of €0.001. Momentum was short lived but meaningful for intraday scalpers and risk traders watching microcap liquidity.
Volume, liquidity and trading signals
Volume spiked to 3,500.00 from an average of 279.00, a relative volume of 12.54 that signals attention from retail or block buyers. The market cap reads about €207,228,256.00 and outstanding shares are 8,289,130,240.00, which creates high float sensitivity to small orders. For intraday strategy, tight stops and limit fills are essential given the low baseline liquidity.
Fundamentals and valuation context for ViewRay, Inc.
ViewRay, Inc. operates in Healthcare, Medical – Devices, selling MRI-guided radiation therapy systems. Trailing metrics show revenue per share 0.57, EPS -0.59, and price to sales 2.38. The company holds cash per share 0.75 and a current ratio of 2.36, which indicate some short-term liquidity despite negative profitability.
Meyka AI grade and technical commentary
Meyka AI rates 6L9.F with a score out of 100: 57.30, Grade C+, Suggestion HOLD. This grade factors S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Technically, the stock sits well below its 50-day average €0.32 and 200-day average €2.72, so any sustained recovery needs follow-through volume above the 50-day level.
Risks, catalysts and sector comparison
Key risks include continued negative EPS, thin liquidity, and a year high of €4.60 that shows prior volatility. Catalysts would be fresh contract wins, clinical data, or corporate news. Sector peers in Medical – Devices show stronger volume and pricings, making ViewRay sensitive to news-driven spikes rather than steady institutional accumulation.
Trading levels, price targets and strategy
Short-term traders should note immediate support near €0.00 to €0.01 and resistance at €0.03 then €0.10. Analysts and our model use measured moves for targets. A conservative trader price target for a confirmed trend is €0.12; risk-tolerant traders may set tactical profit-taking at €0.05. Use stop-losses under recent lows and size positions to manage volatility.
Final Thoughts
Intraday action on 6L9.F stock on 21 Jan 2026 highlights how thinly traded listings can swing sharply on small volumes. The move to €0.025 on XETRA came with 3,500.00 shares and a relative volume of 12.54, a classic high-volume mover signal for short-term traders. Meyka AI’s forecast model projects a 12-month scenario target of €0.12, implying an upside of 380.00% versus the current price of €0.025; forecasts are model-based projections and not guarantees. Given a Meyka AI grade of C+ (57.30) and a HOLD suggestion, investors should weigh positive catalysts against negative EPS and low liquidity. For active traders, confirm volume above the 50-day average and manage risk with tight position sizing. See ViewRay investor updates and filings for primary catalysts and verify intraday order flow through XETRA quotes.
FAQs
What caused the intraday spike in 6L9.F stock today?
The spike to €0.025 on XETRA was driven by a sudden increase in orders and a volume surge to 3,500.00 shares. Low baseline liquidity magnified the move. No major company filing was published at the time, so traders should watch official releases.
How does Meyka AI rate 6L9.F stock and what does it mean?
Meyka AI rates 6L9.F with a score out of 100 at 57.30, Grade C+, Suggestion HOLD. The grade mixes benchmark, sector, growth, metrics and consensus. It is informational and not investment advice.
What is the short-term trading plan for 6L9.F stock?
Short-term traders should use tight stops, watch for volume above the 50-day average, and target profit zones at €0.05 and €0.10. Position size small because liquidity is thin and price swings are large.
Does Meyka AI provide a price forecast for 6L9.F stock?
Meyka AI’s forecast model projects a 12-month scenario price of €0.12, implying a 380.00% upside versus €0.025. Forecasts are model-based projections and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
